Current treatment options for metastatic castar-resistant prostate cancer

Simple item page
dc.contributor.authorRozsypalová Anetacs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorRichter Igorcs
dc.contributor.authorBuka D.cs
dc.contributor.authorGrimová Janacs
dc.contributor.authorMatoušková Michaelacs
dc.date.accessioned2020-06-08T09:38:54Z
dc.date.available20-48-2019en
dc.date.available2020-06-08T09:38:54Z
dc.date.issued2018cs
dc.date.updated29-56-2019en
dc.format.extent4cs
dc.identifier.issn2464-7195cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155560
dc.language.isoczecs
dc.publisherCurrent Media s.r.ocs
dc.publisher.cityPrahacs
dc.relation.ispartofOnkologická Revueen
dc.relation.ispartofseries1cs
dc.subjectmetastatic castration-resistant prostate cancercs
dc.subjectdocetaxelcs
dc.subjectcabazitaxelcs
dc.subjectabirateronecs
dc.subjectenzalutamidecs
dc.subjectradium 223cs
dc.titleCurrent treatment options for metastatic castar-resistant prostate canceren
dc.titleAktuální možnosti léčby metastazujícího kastračně rezistentního karcinomu prostatycs
local.citation.epage1-4cs
local.citation.spage1-4cs
local.identifier.publikace6164
local.relation.issue2cs
Files
Collections